The Next Small Thing: An Update on the Biomedical Revolution

http://www.lilly.com/news/speeches/Pages/060908.aspx

Sidney Taurel Chairman - Eli Lilly and Company December 12, 2008

" I noted earlier that most drugs aren’t effective for all patients. In fact, the average across all drugs is about 50 percent efficacy. And for the 50 percent of the patients who essentially get little or no benefit, whatever they spend is wasted money."

A lot more than money is wasted, IMO.

http://www.lilly.com/news/speeches/Pages/060908.aspx

 

Sidney Taurel Chairman - Eli Lilly and Company December 12, 2008

 

" I noted earlier that most drugs aren’t effective for all patients. In fact, the average across all drugs is about 50 percent efficacy. And for the 50 percent of the patients who essentially get little or no benefit, whatever they spend is wasted money."

 

A lot more than money is wasted, IMO.

 

 

Yep,